ROY A WHITFIELD Insider Trading $NKTR NEKTAR THERAPEUTICS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROY A WHITFIELD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROY A WHITFIELD. ROY A WHITFIELD is Director in INCYTE CORP ($INCY) and Director in NEKTAR THERAPEUTICS ($NKTR) and Director in ILLUMINA INC ($ILMN).
ROY A WHITFIELD in NEKTAR THERAPEUTICS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROY A WHITFIELD: Director
Holdings: 185,850 shares
Current Value: $2,447,645
Latest Transaction: Jan 04 2021
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROY A WHITFIELD in NEKTAR THERAPEUTICS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ILMN, INCY, NKTR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Gift | G | 0.00 | 51,500 | 0 | 51,500 | 0 to 51.5 K |
| Jan 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Gift | G | 0.00 | 51,500 | 0 | 185,850 | 237.4 K to 185.9 K (-21.70 %) |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.91 | 18,200 | 344,162 | 18,200 | |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 9,100 | 0 | 237,350 | 228.3 K to 237.4 K (+3.99 %) |
| Sep 08 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 30,000 | 277,200 | 0 | |
| Sep 08 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 9.24 | 30,000 | 277,200 | 228,250 | 198.3 K to 228.3 K (+15.13 %) |
| Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 10,000 | 92,400 | 30,000 | |
| Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 9.24 | 10,000 | 92,400 | 198,250 | 188.3 K to 198.3 K (+5.31 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 6,500 | 0 | 188,250 | 181.8 K to 188.3 K (+3.58 %) |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 4,750 | 0 | 181,750 | 177 K to 181.8 K (+2.68 %) |
| Jun 07 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 59.80 | 1,400 | 83,720 | 177,000 | 175.6 K to 177 K (+0.80 %) |
| Jun 07 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 59.07 | 2,000 | 118,140 | 175,600 | 173.6 K to 175.6 K (+1.15 %) |
| Jun 07 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 55.22 | 1,600 | 88,352 | 173,600 | 172 K to 173.6 K (+0.93 %) |
| Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 14.26 | 30,000 | 427,800 | 0 | |
| Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 14.26 | 30,000 | 427,800 | 172,000 | 142 K to 172 K (+21.13 %) |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 21.75 | 22,500 | 489,375 | 22,500 | |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 9,000 | 0 | 142,000 | 133 K to 142 K (+6.77 %) |
| Aug 14 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 17.95 | 35,000 | 628,250 | 133,000 | 98 K to 133 K (+35.71 %) |
| Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 14,000 | 117,180 | 0 | |
| Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 14,000 | 117,180 | 98,000 | 84 K to 98 K (+16.67 %) |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 5.14 | 30,000 | 154,200 | 0 | |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 1,000 | 8,370 | 14,000 | |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 5.15 | 15,000 | 77,250 | 0 | |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 5.14 | 30,000 | 154,200 | 84,000 | 54 K to 84 K (+55.56 %) |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 1,000 | 8,370 | 54,000 | 53 K to 54 K (+1.89 %) |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 5.15 | 15,000 | 77,250 | 53,000 | 38 K to 53 K (+39.47 %) |
| Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
| Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 8,000 | 0 | 38,000 | 30 K to 38 K (+26.67 %) |
| Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 0.00 | 15,000 | 0 | 30,000 | 15 K to 30 K (+100.00 %) |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Sep 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.81 | 15,000 | 132,150 | 15,000 | 0 to 15 K |
Page: 1